Grin Therapeutics, Inc.
Clinical trials sponsored by Grin Therapeutics, Inc., explained in plain language.
-
New hope for rare brain disorder: experimental drug enters final testing phase
Disease control Recruiting nowThis study is testing whether a new drug called radiprodil can help control seizures and improve daily living skills in children with GRIN-related neurodevelopmental disorder, a rare genetic condition. About 100 participants will be randomly assigned to receive either the active …
Phase: PHASE3 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
First safety test for new brain drug in people with liver issues
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a potential new drug called radiprodil is processed by the body in people with different levels of liver impairment. The drug is being developed for certain genetic brain disorders. About 40 adults, some with liver problems and some h…
Phase: PHASE1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC